Tech Company Financing Transactions
Sirion Therapeutics Funding Round
On 3/31/2009, Sirion Therapeutics landed $1.1 million in investment from Atlas Venture.
Transaction Overview
Company Name
Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
$1,086,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
3110 Cherry Palm Drive 340
Tampa, FL 33619
USA
Tampa, FL 33619
USA
Phone
Website
Email Address
Overview
Sirion Therapeutics is an ophthalmic-focused company dedicated to the development and commercialization of innovative eye products to address unmet clinician and patient needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Barry Butler
Chief Financial Officer
Todd Creech
Chief Medical Officer
Roger Vogel
Chief Scientific Officer
Nathan Mata
Controller
Yvonne Gallimore
Vice President
Susan Benton
Vice President
Christine Miller
Vice President
Erin Parsons
Vice President
Susan Vaisey
VP - Bus. Development
Philippe Boulangeat
VP - Manufacturing
William Stringer
VP - Marketing
Susan Benton
VP - Marketing
Dave Cobb
VP - Operations
Lisa Butler
VP - Operations
Todd Lehman
VP - Operations
Kimberly Mcleod
VP - Regulatory Affairs
Debra Gessneer
Browse more venture capital transactions:
Prev: 3/31/2009: Viator venture capital transaction
Next: 3/31/2009: Green Dot venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs